NDC 16714-117 – Rivastigmine
Rivastigmine 13.3 mg/24h · Patch, Extended Release · Transdermal
Product NDC16714-117
Product details
- Brand name
- Rivastigmine
- Generic name
- Rivastigmine
- Labeler
- Northstar Rx LLC.
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- ANDA · ANDA206318
- Marketed since
- October 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor
Active ingredients
- Rivastigmine 13.3 mg/24h
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 16714-117-02 | 30 POUCH in 1 CARTON (16714-117-02) / 24 h in 1 POUCH (16714-117-01) | Oct 1, 2019 |
Other Rivastigmine products
- 16714-116 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Northstar Rx LLC.
- 0781-7304 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Sandoz Inc
- 0781-7309 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Sandoz Inc
- 0781-7313 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Sandoz Inc
- 70771-1949 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Zydus Lifesciences Limited
- 70771-1950 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Zydus Lifesciences Limited
- 70771-1951 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Zydus Lifesciences Limited
- 70710-1196 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Zydus Pharmaceuticals USA Inc.
- 70710-1197 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Zydus Pharmaceuticals USA Inc.
- 70710-1198 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Zydus Pharmaceuticals USA Inc.
- 65162-749 Rivastigmine 13.3 mg/24h · Patch · Amneal Pharmaceuticals LLC
- 65162-825 Rivastigmine 4.6 mg/24h · Patch · Amneal Pharmaceuticals LLC